AGIO vs XPEV · rev $65.5M vs rev $895.7M
Agios Pharm (AGIO) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
AGIO currently screens at market cap $1.68B. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the AGIO and XPEV stock pages for the full models.
Not investment advice.